MF
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors (NCT04686682) | Jacobio Pharmaceuticals Co., Ltd. | 2021-05-07 |
| Ruxolitinib in Combination With Autotransplant (NCT02469974) | Marina Kremyanskaya | 2015-05-01 |
Track MF automatically
Every clearance here is in the API, with alerts when new ones post.